IGF-1 DES 1mg

What is IGF-1 DES?

Insulin-like growth factor 1 (IGF-1) is a protein hormone that is structurally similar to insulin. It plays a vital role in regulating cellular growth, differentiation, and metabolism. One of the derivatives of IGF-1 is the IGF-1 DES peptide.

IGF-1 DES (also known as IGF-1 DES 1-3 or DES-IGF-1) is a truncated form of the IGF-1 protein hormone. It is composed of the first three amino acids of the IGF-1 protein (glycine, proline, and glutamic acid) and an additional 13 amino acids. The IGF-1 DES peptide is generated through the removal of the C-terminal extension of the IGF-1 protein.

IGF-1 DES is a potent growth factor that has a higher affinity for the IGF-1 receptor than the native IGF-1 protein. It has a shorter half-life than the IGF-1 protein, which makes it more suitable for certain applications. IGF-1 DES has been shown to promote muscle hypertrophy, improve insulin sensitivity, and enhance fat loss.

Mechanism of action:

IGF-1 DES exerts its effects by binding to the IGF-1 receptor, which is a transmembrane receptor that is expressed on the surface of various cell types. The binding of IGF-1 DES to the IGF-1 receptor activates a signaling pathway that promotes cell growth, differentiation, and survival.

IGF-1 DES has a higher affinity for the IGF-1 receptor than the native IGF-1 protein. This increased affinity allows IGF-1 DES to activate the IGF-1 receptor at lower concentrations than the native IGF-1 protein. Additionally, IGF-1 DES has a shorter half-life than the native IGF-1 protein, which allows for more rapid and transient activation of the IGF-1 receptor.

Applications:

IGF-1 DES has a wide range of applications in the fields of medicine and sports performance. In medicine, IGF-1 DES has been investigated as a potential treatment for muscle wasting, diabetes, and neurodegenerative diseases. In sports performance, IGF-1 DES has been used to enhance muscle hypertrophy, improve recovery, and promote fat loss.

In animal studies, IGF-1 DES has been shown to increase muscle fiber size and improve muscle strength. In human studies, IGF-1 DES has been shown to increase muscle mass and decrease body fat. However, the use of IGF-1 DES in humans is currently prohibited by the World Anti-Doping Agency (WADA) due to its performance-enhancing effects.

Conclusion:

IGF-1 DES is a truncated form of the IGF-1 protein hormone that has a higher affinity for the IGF-1 receptor than the native IGF-1 protein. It exerts its effects by activating a signaling pathway that promotes cell growth, differentiation, and survival. IGF-1 DES has a wide range of applications in medicine and sports performance, but its use in humans is currently prohibited by the WADA. Further research is needed to fully understand the potential benefits and risks of using IGF-1 DES.

Products on the website are not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and are not intended to affect the structure or any function of the body. The use of our products are for only research/laboratory purposes.